SCHEMBL18166555

SCHEMBL18166555

Cn1c(=O)c2c(ncn2CC(=O)NCCc2ccc(C(C)(C)C)cc2)n(C)c1=O

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.70
CYP3A4 P08684 1/20 0.70
ABCC8 Q09428 1/20 0.64
KCNJ11 Q14654 1/20 0.64
RXFP1 Q9HBX9 7/20 0.62
TP53 P04637 3/20 0.62
MAPK1 P28482 2/20 0.62
LMNA P02545 2/20 0.58
GAA P10253 1/20 0.58
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
ADORA2B P29275 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TRPA1 O75762 1/20 0.53
THRB P10828 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1060801 0.90 CYP1A2 (0.72) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL18166736 0.90 CYP1A2 (0.72) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL18166737 0.89 CYP1A2 (0.71) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL1066761 0.89 CYP1A2 (0.71) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL18166663 0.89 CYP1A2 (0.71) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL20161764 0.89 CYP1A2 (0.71) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL1065336 0.87 CYP1A2 (0.78) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL1066585 0.87 CYP1A2 (0.69) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL18166590 0.87 CYP1A2 (0.69) CYP1A2CYP3A4RXFP1TP53MAPK1
SCHEMBL10114294 0.86 RXFP1 (0.68) CYP1A2CYP3A4ABCC8KCNJ11RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 EP disclosed